Literature DB >> 11018221

The impact of substance abuse on the course of bipolar disorder.

S M Strakowski1, M P DelBello, D E Fleck, S Arndt.   

Abstract

BACKGROUND: Substance abuse occurs at high rates in bipolar disorder. The reasons for this co-occurrence are unknown. Alcohol use disorders have been associated with both earlier and later age of onset of bipolar disorder, in part based on the temporal associations of the two conditions. Both drug and alcohol use disorders are associated with impaired outcome of bipolar illness. This influence may involve both direct effects of alcohol or drugs on the initiation of affective symptoms and indirect effects on treatment compliance. To extend these previous findings we examined the temporal associations of substance abuse and affective symptoms in patients with new onset bipolar disorder.
METHODS: Associations between affective symptoms and alcohol and cannabis use disorder symptoms were evaluated using regression and time-series correlative methods in 50 new-onset bipolar patients.
RESULTS: The duration of alcohol abuse during follow-up was associated with the time patients experienced depression. The duration of cannabis abuse was associated with the duration of mania. Several subgroups could be identified with different temporal relationships among these disorders.
CONCLUSIONS: Although the relationships among substance use and bipolar disorders are complex, systematic study of the courses of the disorders might clarify how these conditions interact longitudinally. As the numbers of subjects in specific subgroups are relatively small in this study, these results should be considered preliminary.

Entities:  

Mesh:

Year:  2000        PMID: 11018221     DOI: 10.1016/s0006-3223(00)00900-8

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  42 in total

1.  Impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate.

Authors:  James J Prisciandaro; Stacia M DeSantis; Cody Chiuzan; Delisa G Brown; Kathleen T Brady; Bryan K Tolliver
Journal:  Alcohol Clin Exp Res       Date:  2011-09-20       Impact factor: 3.455

Review 2.  Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives.

Authors:  Simone Tambaro; Marco Bortolato
Journal:  Recent Pat CNS Drug Discov       Date:  2012-04-01

3.  Illness progression as a function of independent and accumulating poor prognosis factors in outpatients with bipolar disorder in the United States.

Authors:  Robert M Post; Lori L Altshuler; Gabriele S Leverich; Willem A Nolen; Ralph Kupka; Heinz Grunze; Mark A Frye; Trisha Suppes; Susan L McElroy; Paul E Keck; Mike Rowe
Journal:  Prim Care Companion CNS Disord       Date:  2014-12-18

Review 4.  Using Lithium in Children and Adolescents with Bipolar Disorder: Efficacy, Tolerability, and Practical Considerations.

Authors:  B Grant; J A Salpekar
Journal:  Paediatr Drugs       Date:  2018-08       Impact factor: 3.022

Review 5.  Brain functional domains inform therapeutic interventions in attention-deficit/hyperactivity disorder and pediatric bipolar disorder.

Authors:  Alessandra M Passarotti; Mani N Pavuluri
Journal:  Expert Rev Neurother       Date:  2011-06       Impact factor: 4.618

Review 6.  The presentation, recognition and management of bipolar depression in primary care.

Authors:  Joseph M Cerimele; Lydia A Chwastiak; Ya-Fen Chan; David A Harrison; Jürgen Unützer
Journal:  J Gen Intern Med       Date:  2013-12       Impact factor: 5.128

Review 7.  Dysregulation of the behavioral approach system (BAS) in bipolar spectrum disorders: review of theory and evidence.

Authors:  Snezana Urosević; Lyn Y Abramson; Eddie Harmon-Jones; Lauren B Alloy
Journal:  Clin Psychol Rev       Date:  2008-05-09

Review 8.  Cognitive functioning in bipolar and co-occurring substance use disorders: a missing piece of the puzzle.

Authors:  Boaz Levy; Roger D Weiss
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

9.  Demographic and clinical characteristics associated with comorbid cannabis use disorders (CUDs) in hospitalized patients with bipolar I disorder.

Authors:  Lauren M Weinstock; Brandon A Gaudiano; Susan J Wenze; Gary Epstein-Lubow; Ivan W Miller
Journal:  Compr Psychiatry       Date:  2015-10-23       Impact factor: 3.735

10.  Excessive substance use in bipolar disorder is associated with impaired functioning rather than clinical characteristics, a descriptive study.

Authors:  Trine V Lagerberg; Ole A Andreassen; Petter A Ringen; Akiah O Berg; Sara Larsson; Ingrid Agartz; Kjetil Sundet; Ingrid Melle
Journal:  BMC Psychiatry       Date:  2010-01-27       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.